NCT06041737Completed
Determination of a Profile of Patients with Renal Failure to Be Supported As a Priority in the Care Pathway in Order to Avoid Emergency Hospitalizations.
Source: ClinicalTrials.gov · Last updated 26 Nov 2024
Brief summary (registry, in English)
The purpose of this study is to map the population of stage 4 and 5 kidney failure patients followed in consultation by the CHSF nephrology team and to determine the factors associated with recurrent hospitalizations.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 405 (actual)
- First submitted
- 11 Sept 2023
- Start date
- 9 Oct 2023
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Centre Hospitalier Sud Francilien
- Diseases
- Chronic kidney disease
- NCT number
- NCT06041737
What you commit to
- Study type: Observational
- Participants enrolled: 405
- From 9 Oct 2023 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Patients informed of the study who objected to the collection of their data.
Who the study is looking for
- Adult patients
- patients with stage 4 or 5 kidney failure who had at least one nephrology consultation during 2020.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Sud Francilien Coordinator of this site? Confirm its status | Corbeil-Essonnes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.